Serum hepatocyte growth factor levels are increased in patients with congestive heart failure. 2001

S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
Department of Cardiology, Jichi Medical School, Minamikawachi-machi, Tochigi, Japan.

BACKGROUND Hepatocyte growth factor (HGF) is a potent endothelial cell-specific mitogen. We investigated the clinical importance of HGF in congestive heart failure (CHF). RESULTS Thirty-five patients with acute exacerbation of CHF and 7 control subjects were examined. Serum and peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood on days 1, 7, and 14 after admission. PBMCs were cultured at a density of 1 x 10(7) cells/mL for 24 hours. HGF levels in serum and the PBMC culture medium and serum interleukin 6 (IL-6) levels were measured by enzyme-linked immunosorbent assay. Serum HGF levels in patients with CHF were markedly increased at admission compared with those in control subjects and gradually returned to control levels during hospitalization. HGF levels in the PBMC culture medium were also significantly increased in CHF patients compared with control subjects. There was a positive correlation between HGF levels in serum or those in the PBMC culture medium and serum IL-6 levels. HGF levels in serum and the culture medium were not notably different between CHF patients regularly treated with and without angiotensin-converting enzyme inhibitors. CONCLUSIONS HGF levels in serum are increased in patients with acute exacerbation of CHF.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
January 1995, Nephron,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
January 2002, Gastroenterologie clinique et biologique,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
February 2007, European journal of heart failure,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
June 1999, Hypertension (Dallas, Tex. : 1979),
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
January 1992, Hepatology (Baltimore, Md.),
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
January 2000, Journal of medicine,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
June 1983, Journal of the American College of Cardiology,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
January 1999, American journal of nephrology,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
April 1996, Journal of hepatology,
S Ueno, and U Ikeda, and Y Hojo, and H Arakawa, and M Nonaka, and K Yamamoto, and K Shimada
January 1963, Cor et vasa,
Copied contents to your clipboard!